Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome
Clinical trial NCT03031821 · TERMINATED
Trial details
- NCT number
- NCT03031821
- Sponsor
- Canadian Urologic Oncology Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2023-11-24
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.